Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$19.44 USD

19.44
937,477

+0.10 (0.52%)

Updated Aug 30, 2024 04:00 PM ET

After-Market: $19.44 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 10% (225 out of 251)

Industry: Chemical - Diversified

Better trading starts here.

Zacks News

Chemours (CC) Opens Cutting-Edge Facility for EV Batteries

Chemours (CC) opens the Chemours Battery Innovation Center to advance sustainable battery technology for electric vehicles.

Chemours (CC) Earnings Miss, Revenues Beat Estimates in Q2

Chemours' (CC) earnings miss estimates in the second quarter due to lower selling prices.

Chemours (CC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Chemours (CC) Misses Q2 Earnings Estimates

Chemours (CC) delivered earnings and revenue surprises of -42.42% and 0.01%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Anindya Barman headshot

Can These 4 Chemical Stocks Hit Targets This Earnings Season?

Chemical companies are expected to have benefited from demand recovery across key end markets and moderated de-stocking activities. Let's see how APD, CE, CC and AXTA are poised ahead of their earnings releases.

Do Options Traders Know Something About Chemours (CC) Stock We Don't?

Investors need to pay close attention to Chemours (CC) stock based on the movements in the options market lately.

Analysts Estimate LyondellBasell (LYB) to Report a Decline in Earnings: What to Look Out for

LyondellBasell (LYB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Chemours (CC) Q2 Earnings Expected to Decline

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours (CC) Soars 5.5%: Is Further Upside Left in the Stock?

Chemours (CC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Chemours (CC) Announces Enhancement of EVOLVE 2030 Methodology

The revised EVOLVE 2030 approach improves Chemours' (CC) ability to integrate its business processes with this goal.

Why Is Chemours (CC) Down 2.1% Since Last Earnings Report?

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Chemours (CC) Earnings Beat, Revenues Miss Estimates in Q1

Lower volumes and prices hurt Chemours' (CC) top line in the first quarter.

Chemours (CC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Chemours (CC) Q1 Earnings Surpass Estimates

Chemours (CC) delivered earnings and revenue surprises of 28% and 0.76%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Chemours (CC) Up 2.9% Since Last Earnings Report: Can It Continue?

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Stepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemours (CC) Recently Broke Out Above the 20-Day Moving Average

Should investors be excited or worried when a stock crosses above the 20-day simple moving average?

Chemours (CC) Just Reclaimed the 50-Day Moving Average

Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?

Company News for Apr 1, 2024

Companies In The News Are: RH, AMC, CC, WBA.

Chemours (CC) Q4 Earnings Beat, Revenue Miss Estimates

Chemours (CC) fourth-quarter earnings beat estimates, while sales miss despite growth across TT and TSS segments.

Chemours (CC) Q4 Earnings Top Estimates

Chemours (CC) delivered earnings and revenue surprises of 6.90% and 0.69%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Is Chemours (CC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy Chemours (CC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Eastman Chemical (EMN) Gains on Cost Cuts and Innovation

Eastman Chemical (EMN) benefits from cost-management actions and innovation amid challenges from soft demand and consumer de-stocking in certain markets.